GenCell Biosystems
Limerick · Founded 2011
About GenCell Biosystems
GenCell Biosystems is developing revolutionary technologies for molecular biology. GenCell Biosystems is commercializing a number of instruments based upon their innovative Composite Liquid Cell platform technology. Composite Liquid Cells (CLCs) provide an entirely new method of confining, transporting, combining, processing and analysing biological reactions to yield valuable data. With applications including sample extraction and preparation, library preparation for next-gen sequencing, PCR genotyping, qPCR, digital PCR and proteomic assays, CLCs are versatile and can be tailored to suit virtually all protocol requirements.
Company Facts
- Founded: 2011
- Legal name: GenCell Biosystems Ltd.
- Operating status: Acquired
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $3.7M
- Funding stage: M&A
- Last round: Seed (Jan 2014)
- Website: gencellbio.com
- Phone: +353 61 307 734
Social Profiles
Canonical: https://fsome.com/organization/gencell-biosystems-8267555 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.